3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
8
Leukemia, Myeloid, Acute
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Hodgkin Disease
4
Recurrence
3
Hematologic Neoplasms
3
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Ganglioneuroblastoma
2
Burkitt Lymphoma
2
Anemia, Refractory, with Excess of Blasts
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Sezary Syndrome
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Plasmablastic Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Interventions
Magnetic Resonance Spectroscopy
13
Temozolomide
12
Specimen Handling
8
X-Rays
7
Biopsy
7
Nuclear Medicine Department, Hospital
6
Radiation
5
Phantoms, Imaging
5
trametinib
4
erdafitinib
4
dabrafenib
4
ulixertinib
3
larotrectinib
3
Radiotherapy
3
tipifarnib
2
selpercatinib
2
palbociclib
2
olutasidenib
2
olaparib
2
ivosidenib
2
ensartinib
2
binimetinib
2
Nivolumab
2
D2C7-(scdsFv)-PE38KDEL
2
vorasidenib
1
veliparib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
tazemetostat
1
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
Melphalan
×
30 days
×
Clear all
No trials found.